Russian government to start checks for GMP compliance of domestic drug producers
The Russian government plans to start massive checks of the domestic producers of drugs, as well as drug importers for their compliance of products with Good Manufacturing Practices (GMP) standards, which became mandatory in Russia since the beginning of the current year, according to an official representative of the Russian Ministry of Industry and Trade.
It is planned that all the checks will be completed by 2018. According to the Industry and Trade Ministry, at present only 80% of drugs in value terms and 67% by volume produced by the enterprises comply with GMP standards.
According to Olga Kolotilova, director of the Department of Development of Pharmaceutical and Medical Industry of the Russian Ministry of Industry and Trade, these state plans will be stipulated in the existing federal law “On the Turnover of Drugs in Russia."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
More on this story...
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze